An investigational antibiotic effective against Gram positive and Gram negative bacteria, which is a non-peptide small molecule modeled after host defense peptides (HDPs). It is currently under clinical trials for the treatment of head and neck neoplasms as well as mucositis.
https://www.bocsci.com/brilacidin-cas-1224095-98-0-item-475173.html
Original
